Related Experiment Video
Updated: Feb 2, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2 mice
Renxue Wang1, Jonathan A Sheps1, Lin Liu1
1BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Abstract:
Bile acid imbalance causes progressive familial intrahepatic cholestasis type 2 (PFIC2) or type 3 (PFIC3), severe liver diseases associated with genetic defects in the biliary bile acid transporter bile salt export pump (BSEP; ABCB11) or phosphatidylcholine transporter multidrug resistance protein 3 (MDR3; ABCB4), respectively. Mdr2 mice (a PFIC3 model) develop progressive cholangitis, ductular proliferation, periportal fibrosis, and hepatocellular carcinoma (HCC) because the nonmicelle-bound bile acids in the bile of these mice are toxic. We asked whether the highly hydrophilic bile acids generated by Bsep mice could protect Mdr2-/- mice from progressive liver damage. We generated double-KO (DKO: Bsep-/- and Mdr2 ) mice. Their bile acid composition resembles that of Bsep-/- mice, with increased hydrophilic muricholic acids, tetrahydroxylated bile acids (THBAs), and reduced hydrophobic cholic acid. These mice lack the liver pathology of their Mdr2 littermates. The livers of DKO mice have gene expression profiles very similar to Bsep-/- mice, with 4,410 of 6,134 gene expression changes associated with the Mdr2 mutation being suppressed. Feeding with THBAs partially alleviates liver damage in the Mdr2 mice. Hydrophilic changes to biliary bile acid composition, including introduction of THBA, can prevent the progressive liver pathology associated with the Mdr2 (PFIC3) mutation.
Insights
Highly hydrophilic bile acids, like those in Bsep mice, can prevent liver damage in Mdr2 mice, a model for progressive familial intrahepatic cholestasis type 3. This suggests a potential therapeutic strategy for liver diseases caused by bile acid imbalance.
Area of Science:
- Hepatology and Gastroenterology
- Molecular and Genetic Medicine
- Bile Acid Metabolism
Background:
- Progressive familial intrahepatic cholestasis types 2 and 3 (PFIC2/PFIC3) are severe liver diseases caused by genetic defects in bile salt export pump (BSEP) and multidrug resistance protein 3 (MDR3), respectively.
- Mdr2 knockout mice, a model for PFIC3, develop liver pathology including cholangitis, fibrosis, and hepatocellular carcinoma due to toxic, non-micelle-bound bile acids.
- Bsep knockout mice exhibit altered bile acid profiles with increased hydrophilic bile acids.
Purpose of the Study:
- To investigate whether the hydrophilic bile acid profile of Bsep knockout mice can protect against liver damage in Mdr2 knockout mice (PFIC3 model).
- To assess the therapeutic potential of hydrophilic bile acids in mitigating liver pathology associated with MDR3 deficiency.
Main Methods:
- Generation of double knockout (DKO) mice lacking both Bsep and Mdr2.
- Analysis of bile acid composition and liver pathology in DKO mice compared to single knockouts.
- Gene expression profiling of DKO mouse livers.
- Administration of tetrahydroxylated bile acids (THBAs) to Mdr2 mice to evaluate protective effects.
Main Results:
- DKO mice exhibited bile acid profiles similar to Bsep mice, characterized by increased hydrophilic muricholic acids and THBAs, and reduced hydrophobic cholic acid.
- DKO mice were protected from the liver pathology observed in Mdr2 littermates, with suppressed gene expression changes associated with the Mdr2 mutation.
- Feeding THBAs partially alleviated liver damage in Mdr2 mice, indicating a protective role of hydrophilic bile acids.
Conclusions:
- Altering biliary bile acid composition towards more hydrophilic forms, including the introduction of THBAs, can prevent progressive liver disease in the Mdr2 (PFIC3) mouse model.
- This study highlights the potential of modulating bile acid hydrophilicity as a therapeutic strategy for PFIC3 and related liver conditions.
Related Concept Videos
Bile
Bile is released when dietary fats enter...
Amino acids
Cancer Prevention
Some...
Accessory Organs
Prevention of Further Absorption of Poison
Preventive Healthcare Services

